Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance (original) (raw)

Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier

Miljan Milosevic

Journal of Controlled Release, 2015

View PDFchevron_right

Determinants of drug delivery and transport to solid tumors

Chiung-tong Chen

Journal of Controlled Release, 2001

View PDFchevron_right

Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics

Miljan Milosevic

Drug delivery, 2015

View PDFchevron_right

Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery

Vincent Gregoire

Molecular Cancer Therapeutics, 2006

View PDFchevron_right

Vascular Permeability and Drug Delivery in Cancers

jagoda hebda

Frontiers in Oncology, 2013

View PDFchevron_right

Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers

Ashutosh Chilkoti

JNCI Journal of the National Cancer Institute, 2006

View PDFchevron_right

Three-dimensional models of chemotherapeutic agent transport in tumours

Szabolcs Modok

2010

View PDFchevron_right

Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

Amanda Roberts

Clinical Cancer Research, 2010

View PDFchevron_right

A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors

JINZI ZHENG

PLoS ONE, 2013

View PDFchevron_right

Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer

Michal Pechar

Journal of Controlled Release, 2023

View PDFchevron_right

Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux

Clarissa Willers

Journal of Cancer Research and Clinical Oncology, 2019

View PDFchevron_right

Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here

Michele Caraglia

Current Drug Metabolism, 2012

View PDFchevron_right

Microtechnologies for mimicking tumor-imposed transport limitations and developing targeted cancer therapies

Bhushan Toley

2012

View PDFchevron_right

Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model

Roger D. Kamm

Advanced Functional Materials

View PDFchevron_right

The Tumor Microenvironment and Strategies to Improve Drug Distribution

Jasdeep Saggar

Frontiers in Oncology, 2013

View PDFchevron_right

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

Arun Iyer, Jun Fang

Advances in Enzyme Regulation, 2001

View PDFchevron_right

Physical barriers to drug delivery in tumors

Brendan Curti

Critical Reviews in Oncology/Hematology, 1993

View PDFchevron_right

Evaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT)

Kevin Chu

Journal of Nanoparticle Research, 2014

View PDFchevron_right

Strategic consideration for effective chemotherapeutic transportation via transpapillary route in breast cancer

Bala Prabhakar

International Journal of Pharmaceutics, 2020

View PDFchevron_right

A Systems Approach for Tumor Pharmacokinetics

Greg Thurber

PLoS ONE, 2011

View PDFchevron_right

The benefits and challenges associated with the use of drug delivery systems in cancer therapy

Edna Cukierman

Biochemical Pharmacology, 2010

View PDFchevron_right

Evaluation of the enhanced permeability and retention effect in the early stages of lymph node metastasis

Ariunbuyan Sukhbaatar

Cancer Science, 2017

View PDFchevron_right

Particle Carriers for Combating Multidrug-Resistant Cancer

Yan Yan

ACS Nano, 2013

View PDFchevron_right

Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy

Martin Nowak

View PDFchevron_right

Contribution of tumoral and host solute carriers to clinical drug response

Torben Mikkelsen

Drug Resistance Updates, 2012

View PDFchevron_right

Drug delivery to tumours: recent strategies

Harivardhan Reddy L.

Journal of Pharmacy and Pharmacology, 2005

View PDFchevron_right

Drug Delivery in Oncology. From Basic Research to Cancer Therapy. 3 Volumes. Edited by Felix Kratz, Peter Senter and Henning Steinhagen

Drazen Raucher

Angewandte Chemie International Edition, 2014

View PDFchevron_right

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Susan Hobbs

Proceedings of the National Academy of Sciences, 1998

View PDFchevron_right

Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules

Paolo A Netti

Proceedings of the National Academy of Sciences of the United States of America, 1999

View PDFchevron_right

Exploiting the enhanced permeability and retention effect for tumor targeting

Jun Fang

Drug Discovery Today, 2006

View PDFchevron_right

Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy

sonu kumar gupta ME 42

Oncology Reviews, 2020

View PDFchevron_right

Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

Robert Campbell

Proceedings of the National Academy of Sciences, 2001

View PDFchevron_right

Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer

Szabolcs Modok

Current Opinion in Pharmacology, 2006

View PDFchevron_right

Scaling rules for diffusive drug delivery in tumor and normal tissues

James Baish

Proceedings of the National Academy of Sciences, 2011

View PDFchevron_right